S'abonner

Trends in management of pelvic organ prolapse among female Medicare beneficiaries - 17/12/14

Doi : 10.1016/j.ajog.2014.10.025 
Aqsa A. Khan, MD a, Karyn S. Eilber, MD b, J. Quentin Clemens, MD c, Ning Wu, PhD d, Chris L. Pashos, PhD d, Jennifer T. Anger, MD, MPH b,
a Department of Urology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 
b Urologic Reconstruction, Urodynamics, and Female Urology, Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA 
c Department of Urology, University of Michigan Medical School, Ann Arbor, MI 
d United BioSource Corporation, Lexington, MA 

Corresponding author: Jennifer T. Anger, MD, MPH.
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 17 December 2014
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Objective

In the last decade, many new surgical treatments have been developed to achieve less-invasive approaches to prolapse management. However, limited data exist on how the patterns of care for women with pelvic organ prolapse (POP) may have changed over the last decade, and whether mesh implantation techniques have influenced the type of specific compartment repair performed. We used a national data set to analyze the temporal trends in patterns of care for women with POP.

Study Design

Data were obtained from Public Use Files from the Centers for Medicare and Medicaid Services for a 5% random sample of national beneficiaries with an International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis of POP from 1999 through 2009. Current Procedural Terminology, 4th Edition and International Classification of Diseases, Ninth Revision, Clinical Modification procedure codes were used to evaluate nonsurgical and surgical management trends for this cohort. Types of surgery were categorized by prolapse compartment and combinations of repairs. After 2005, when applicable codes became available, mesh or graft repairs were also analyzed.

Results

Over the study time period, the number of women with a diagnosis of POP in any 1 year in our 5% sample of Medicare beneficiaries remained relatively stable (range, 21,245–23,268 per year). Rates of pessary insertion were also consistent at 11-13% over the study period. Of the women with a prolapse diagnosis, 14-15% underwent surgical repair, and there was little change over time in surgical management patterns based on compartment. Most commonly, multiple compartments were repaired simultaneously. There was a rapid increase in mesh use such that in 2009, 41% of all women who underwent surgery (5.8% of the total cohort) had mesh or graft inserted in their repair. Hysterectomy rates for prolapse decreased over time. Rates of vault suspension at the time of hysterectomy for prolapse were low; however, they showed a relative increase over time (22% in 1999 to 26% in 2009).

Conclusion

Patterns and rates of prolapse repairs remained relatively unchanged from 1999 through 2009, with an exception of a rapid rise in mesh use. These data suggest that the majority of mesh techniques were used for augmentation purposes only, but did not result in an increase in apical repairs performed in the United States. There remains a disappointingly low rate of vault suspension repairs concomitantly at time of hysterectomy for POP.

Le texte complet de cet article est disponible en PDF.

Key words : epidemiology, mesh, pelvic organ prolapse, trends


Plan


 Funded by a Patient-Oriented Research Career Development Award (number 1 K23 DK080227) from the National Institute of Diabetes and Digestive and Kidney Diseases and an American Recovery and Reinvestment Act Supplement (number 5K23DK080227), both to J.T.A.
 K.S.E. is a speaker for Astellas Pharma, an investigator and consultant for American Medical Systems, and an investigator for Boston Scientific. The remaining authors report no conflict of interest.
 Cite this article as: Khan AA, Eilber KS, Clemens JQ, et al. Trends in management of pelvic organ prolapse among female Medicare beneficiaries. Am J Obstet Gynecol 2014;211:x.ex-x.ex.


© 2014  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.